Becton Dickinsonvs.ResMed
BDX vs RMD · both in Medtech & devices, part of the Medicine, pharma & life science value chain: Medical equipment and devices — from surgery and cardiology to robotics.
Becton Dickinson is about 1.4× larger than ResMed by market cap; ResMed trades at the lower P/E (19.6 vs 36.8); year to date, Becton Dickinson leads (−0.4% vs −15.4%).
Side by side
| BDX | RMD | |
|---|---|---|
| Market cap | $41.9B | $29.8B |
| Price | $151.94 | $203.87 |
| Today | +0.7% | −2.2% |
| Return YTD | −0.4% | −15.4% |
| Return 1Y | +8.9% | −21.0% |
| P/E | 36.8 | 19.6 |
| P/S | 2.0 | 5.4 |
| P/B | 1.7 | 4.6 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
Becton DickinsonBDX
American medtech group with a broad portfolio of medical consumables, diagnostics and drug delivery (syringes, needles).
Full BDX profile →More comparisons in Medtech & devices
See where BDX and RMD sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →